Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A second ezetimbe/statin combination has been approved by the FDA for the treatment of hyperlipidemia. Ezetimibe is now combined with atorvastatin and is marketed by Merck & Co. as Liptruzet.

Pharmacology Update: Ezetimibe and Atorvastatin Tablets (Liptruzet™)